According to our data, NOS2 was one of the most significantly affected FRGs, and the most obvious expression differences between high risk and low risk groups patients, therefore we began to explore the biological functions and the molecular mechanism of NOS2 in CRC. This evidence concerns the gene NOS2 and colorectal carcinoma.